Plasmonic heating by indium tin oxide nanoparticles: spectrally enabling decoupled near-infrared theranostics

All-optical theranostic systems are sought after in nanomedicine, since they combine in a single platform therapeutic and diagnostic capabilities. Commonly in these systems the therapeutic and diagnostic/imaging functions are accomplished with plasmonic photothermal agents and luminescent nanoparticles (NPs), respectively. For maximized performance and minimized side effects, these two modalities should be independently activated, i.e., in a decoupled way, using distinct near infrared (NIR) wavelengths: a radiation window wherein photon-tissue interaction is reduced. Yet, to date, a fully decoupled NIR theranostics system is not available. Finding plasmonic NPs working in that range and without spectral overlap with the absorption and emission of state-of-the-art NIR luminescent NPs requires the development of new materials specifically designed for this purpose. To address this limitation, we herein present water-dispersible indium tin oxide (ITO) NPs whose surface plasmon resonance was tuned for exclusive operation in the third biological window (NIR-III, 1500-1800 nm). That leaves available the first and second biological windows, in which diagnostic tools are typically working. Both the microwave-assisted synthesis and the water-transfer protocol were optimized to obtain NPs with maximum light-to-heat conversion capabilities, owing to their small size and reduced aggregation in aqueous media. Proof-of-concept experiments showed that the lack of overlap between the absorption of ITO NPs and the absorption/emission of model near infrared luminescent species (the widely used Nd³⁺-doped NPs) is an asset when devising an all-optical theranostics platform. The obtained results set the stage for the development of a new generation of high-performance, all-optical theranostic systems with minimized side effects.